国会议员调查FDA新优先审评券计划,指涉腐败与审查仓促问题
Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns
生物技术与制药领域的最新动态
Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns
GE HealthCare presents photon-counting CT system for FDA review
AbbVie launches lab space award program for Quebec biotechs
FTC outlines antitrust case against Edwards' $945M JenaValve acquisition
US commission recommends federal research revamp to avoid losing global biotech edge
Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3
CDC updates website to say vaccines may cause autism without new evidence
The Cooper Companies under activist pressure to split—in different ways
Moderna's reshaping rolls on with 3 more pipeline purges
How a 'healthy exchange of ideas' with RFK Jr. kick-started FDA's gene therapy push
GE HealthCare to acquire imaging software provider Intelerad for $2.3B
Fierce Biotech Layoff Tracker 2025: Applied Tx lays off 46% of staff; Ensoma makes cuts
In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation
Contineum's J&J-partnered MS drug fails to improve vision in phase 2
FDA says it's hiring more than 1,000 new staffers, launches new comms program for review process
GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement
Nurix trims workforce as pivotal trial for lead BTK degrader kicks off
Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests
Chutes & Ladders—Gilead abruptly parts ways with general counsel
CDC instructs researchers to end all monkey studies by year-end: Science